Search International and National Patent Collections

1. (WO2017168170) IMMUNO-MODULATORY PROGENITOR (IMP) CELL EXPRESSING ONE OR MORE OF CD3, CD3E, CD8, CD8B, CD4, CD5, CD6 AND CD7

Pub. No.:    WO/2017/168170    International Application No.:    PCT/GB2017/050917
Publication Date: Fri Oct 06 01:59:59 CEST 2017 International Filing Date: Sat Apr 01 01:59:59 CEST 2017
IPC: A61K 35/28
C12N 5/078
Applicants: CELL THERAPY LIMITED
Inventors: REGINALD, Ajan
Title: IMMUNO-MODULATORY PROGENITOR (IMP) CELL EXPRESSING ONE OR MORE OF CD3, CD3E, CD8, CD8B, CD4, CD5, CD6 AND CD7
Abstract:
The invention relates to immuno-modulatory progenitor (IMP) cells expressing one or more of CD3, CD3E, CD8, CD8B, CD4, CD5, CD6 and CD7and their use in therapy.